https://www.selleckchem.com/pr....oducts/oxidopamine-h
Molecular models in many cancer types showed mutual influences between immune responses and vascular normalization. Recently, clinical trials are investigating the efficacy of the association between anti-angiogenetic agents and immune-checkpoint inhibitors to treat advanced stage melanoma. This paper reviews the biological bases of angiogenesis in melanoma and summarizes the currently available clinical data on the use of anti-angiogenetic compounds in melanoma.Therapeutic vaccines can elicit tumor-specific cytotoxic T
Like
Comment
Share
